Loading the dossier
The Hill Wire · Member dossier
Robert B. Aderholt
RepublicanRepresentative · AL-4
Chair, Appropriations subcommittee on Labor, Health and Human Services, Education, and Related AgenciesCurrent term began Jan 2025Quiet since Sep 2025
Fewer than five priced purchases on the record, so no comparison to the index is drawn.
- Disclosed trades
- 1
- 0 purchases · 1 sale · made public since January 2025
- Disclosed volume
- $8K
- midpoints of the reported ranges, not what Aderholt owns
- Made public
- 44 days
- Half of Aderholt's trades were made public within 44 days; Congress overall 28; the law allows 45.
- On time
- 100%
- 79% across Congress
A U.S. representative from Alabama and an attorney
Robert B. Aderholt is an attorney and politician from Alabama. He has represented Alabama's 4th congressional district since 1997 and serves on the House Committee on Appropriations.
Aderholt's legal background provides context in law, while his Appropriations work involves allocating federal funds. His committee assignments cover agriculture, defense, labor, health and education.
attorney · politician
Generated with AI, awaiting an editor · from Wikipedia · not from the filings
What the filings show
An Alabama Republican whose disclosed trading is limited to sales of GSK shares
The record is too limited to establish an investing approach, though reported activity follows a regular pace. Disclosed trading consists of sales of GSK American Depositary Shares, leaving the activity narrowly focused on health care. The holdings are reported in his own name, with no funds or options disclosed.
What to watch
- Additional disclosures would help show whether GSK sales are part of a recurring approach.
- Filings have met the reporting deadline, but the delay still limits how current the trading picture is.
- Activity beyond GSK would broaden a record currently confined to health care.
Generated with AI, awaiting an editor, from the member’s own filings · carries no figures and makes no claim about performance
Public information from STOCK Act filings. Amounts are reported in ranges and shown as midpoints, filings arrive after the trades, and no personal profit or loss is disclosed. Not financial advice.